Reduction in Platelet Reactivity With Prasugrel 5 mg in Low-Body-Weight Patients Is Noninferior to Prasugrel 10 mg in Higher-Body-Weight Patients-Reference-Cited by-同舟云学术

Reduction in Platelet Reactivity With Prasugrel 5 mg in Low-Body-Weight Patients Is Noninferior to Prasugrel 10 mg in Higher-Body-Weight Patients

Published:2012-11 Issue:20 Volume:60 Page:2032-2040
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Erlinge David,ten Berg Jurrien,Foley David,Angiolillo Dominick J.,Wagner Henrik,Brown Patricia B.,Zhou Chunmei,Luo Junxiang,Jakubowski Joseph A.,Moser Brian,Small David S.,Bergmeijer Thomas,James Stefan,Winters Kenneth J.

Funder

Bristol-Myers Squibb

sanofi-aventis

GlaxoSmithKline

Otsuka

Eli Lilly and Co.

Daiichi Sankyo Co., Ltd.

The Medicines Co.

Portola

Accumetrics

Schering-Plough

AstraZeneca

Eisai

Merck

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference10 articles.

1. Prasugrel versus clopidogrel in patients with acute coronary syndromes;Wiviott;N Engl J Med,2007

2. Population pharmacokinetic analyses to evaluate the influence of intrinsic and extrinsic factors on exposure of prasugrel active metabolite in TRITON-TIMI 38;Wrishko;J Clin Pharmacol,2009

3. Prasugrel (Effient),2012

4. Prasugrel (Efient) European Union Summary of Product Characteristics,2012

5. Relationship between exposure to prasugrel active metabolite and clinical outcomes in the TRITON-TIMI 38 substudy;Riesmeyer;J Clin Pharmacol,2012

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic/Pharmacodynamic Assessment of the Structural Refinement of Clopidogrel Focusing on the Balance between Bioactivation and Deactivation;Drug Metabolism and Disposition;2024-05-10

2. Current Strategies to Guide the Antiplatelet Therapy in Acute Coronary Syndromes;International Journal of Molecular Sciences;2024-04-03

3. Low-dose prasugrel versus standard-dose ticagrelor in east Asian patients with acute coronary syndrome;Journal of Thrombosis and Thrombolysis;2024-03-31

4. Antiplatelet Therapy in Neurointervention;Seminars in Neurology;2023-06

5. Antiplatelet therapy for coronary artery disease in 2023: current status and future prospects;Expert Review of Cardiovascular Therapy;2023-04-19